Country Guide: Filing a Patent in Pakistan

Pakistan is the world's fifth most populous country with over 230 million people, making it larger than Brazil, Russia, or Mexico. Its economy encompasses significant pharmaceutical manufacturing, textiles, agriculture, telecommunications, construction, and a rapidly growing technology sector. Karachi is South Asia's largest financial centre outside India, and Pakistan's geographic position — between India, China, Afghanistan, Iran, and the Arabian Sea — makes it a strategic crossroads for regional trade.

For most international inventors, Pakistan falls into a category of patent jurisdictions that are filed without much thought or skipped entirely. This guide argues for a more deliberate approach — not because Pakistani patent enforcement rivals Germany or the US, but because Pakistan's market scale, its pharmaceutical manufacturing significance, and its growing role in regional supply chains make a considered IP strategy distinctly worthwhile for the right technology areas.

The Hard Truth About Pakistani Patents

Pakistan's patent system exists in a state of deliberate underperformance — not because the law is fundamentally flawed, but because the gap between Pakistan's legal IP framework and its operational implementation remains wide.

Pakistan's Patents Ordinance 2000, supplemented by the Patents Rules 2003, is a reasonably modern statute — drafted to TRIPS compliance and incorporating standard patentability criteria. Pakistan's Intellectual Property Organization (IPO-Pakistan), established in 2005, administers patents, trademarks, copyrights, and industrial designs. The legal architecture is there.

The operational reality is different. IPO-Pakistan's examination capacity is limited. Patent examination timelines routinely run 5–8 years or longer. The patent registry has historically suffered from administrative backlogs, paper-based processes (improving with digitisation efforts), and limited examiner technical depth across specialised technology areas. Enforcement through Pakistani courts — the Intellectual Property Tribunal system, established 2012 — is improving but remains slow and inconsistent.

The critical insight: Pakistan's IP system rewards patience and long-term thinking. For technology areas where Pakistan is commercially significant over a 10–20 year horizon — pharmaceuticals, agricultural technology, construction materials, telecommunications infrastructure, consumer goods — filing now, accepting slow prosecution, and building a patent position that will mature as Pakistan's enforcement infrastructure improves is a legitimate strategic choice. For technology with a 3-year commercial window, Pakistani patents may grant too late to provide protection during the relevant period.

IPO-Pakistan: Overview

The Intellectual Property Organization of Pakistan is headquartered in Islamabad with offices in Karachi and Lahore. IPO-Pakistan administers patents, trademarks, copyrights, integrated circuit layout designs, and plant breeders' rights.

Language: All IPO-Pakistan filings must be in English — Pakistan's co-official language and the working language of its legal system and government. This makes Pakistan one of the most accessible patent jurisdictions globally for English-speaking applicants: no translation required, no translation costs.

Patent types:

Patent:

• Term: 20 years from filing date
• Examination: Full substantive examination (in principle; see execution caveat above)
• Covers: New inventions capable of industrial application

What Is Patentable in Pakistan

Pakistan's Patents Ordinance 2000 (Section 7) specifies that any new and useful art, process, method or manner of manufacture, machine, apparatus, or other article, or substance produced by manufacture, including any new and useful improvement of any of them, may be patented.

Not patentable (Section 7(3) and Section 10):

• Discoveries, scientific theories, mathematical methods
• Plants and animals (other than microorganisms), and essentially biological processes for producing them
• Business methods, computer programs as such, and rules for performing mental acts
• Methods of diagnostic, therapeutic, or surgical treatment of humans or animals
• Inventions whose publication or exploitation would be contrary to public order or morality
• Inventions capable of use only in or for the production or use of weapons of mass destruction — a specific exclusion that reflects Pakistan's national security framework

Pharmaceutical patents — the TRIPS flexibility context: Pakistan is a developing country entitled to certain TRIPS flexibilities. Pakistan has not formally adopted the LDC pharmaceutical waiver (it is not classified as an LDC), but its compulsory licensing provisions and the practical enforcement environment mean that pharmaceutical patent enforcement against domestic generic manufacturers has historically been challenging. The 2020 amendments to Pakistan's pharmaceutical regulatory framework and ongoing discussions about TRIPS flexibilities make pharmaceutical patent strategy in Pakistan particularly nuanced.

Software and computer-implemented inventions: Pakistan's treatment of software patents follows the "as such" exclusion principle — pure software is not patentable, but software implemented to produce a technical result or forming part of a technical invention may be patentable with appropriate claim drafting. IPO-Pakistan's examination practice on this issue is less developed than at the EPO or USPTO, creating some uncertainty in prosecution.

Pakistan's Patent Filing Process

Filing Routes

Direct national filing at IPO-Pakistan:

Applications are filed at IPO-Pakistan's Patent Office in Islamabad. Since 2019, IPO-Pakistan has been progressively moving to an online filing system (e-IPO portal), though paper filing remains accepted.

Requirements for direct filing:

• Application form
• Complete specification (description, claims, abstract)
• Drawings if required to understand the invention
• Patent agent appointment (required for foreign applicants)
• Payment of government fees

Paris Convention Priority Filing:

Pakistan is not a member of the Patent Cooperation Treaty (PCT) — one of the few major economies worldwide that has not joined. This means you cannot designate Pakistan in a PCT application and cannot enter a Pakistani "national phase." This is the single most important procedural fact about Pakistani patent filing and catches many inventors off guard.

To file in Pakistan while claiming priority from an earlier foreign application, you must use the Paris Convention route: file directly at IPO-Pakistan within 12 months of your earliest priority date (e.g., a US provisional or a UK national filing). This is a shorter window than the 30-month PCT timeline available in most other countries, requiring earlier planning and budgeting.

Paris Convention filing requirements:

• Direct national application at IPO-Pakistan
• Certified copy of the priority document
• Appointment of a Pakistani patent agent
• Payment of government fees
• No translation required — English is accepted

Patent Agent Requirement

Foreign applicants must appoint a licensed Pakistani patent agent to file and prosecute patents at IPO-Pakistan. The Patent and Design Institute of Pakistan maintains the list of registered patent agents. The Pakistan Bar Council and specialist IP law firms in Karachi and Lahore provide patent agent services.

Government Fees

Pakistani government fees are among the lowest of any substantively examining patent office globally:

Note: PKR amounts are subject to significant currency fluctuation; verify current USD equivalents with a Pakistani patent agent at filing.

Request for Examination

Pakistan requires a separate examination request. The examination request must be filed within 4 years of the filing date — one of the longer examination request windows of any major patent office. This provides significant flexibility to defer examination costs while assessing commercial traction.

Examination at IPO-Pakistan

The Examination Reality

IPO-Pakistan conducts substantive examination — novelty, inventive step, and industrial applicability — in principle. The practical reality of Pakistani examination reflects the office's resource constraints:

Search methodology: IPO-Pakistan examiners have access to international patent databases but rely heavily on search reports from other offices — international search reports from the applicant's home jurisdiction are given significant weight. Applications that arrive with a positive examination history at the USPTO or EPO typically receive a smoother examination experience than those without prior international search support.

Examiner technical depth: IPO-Pakistan's examiner corps covers broad technology areas with limited specialisation depth in cutting-edge fields. Standard mechanical, electrical, and chemical patent applications receive competent treatment. Highly specialised biotechnology, semiconductor, or AI-related claims may receive less sophisticated analysis.

Backlog and timelines: First examination actions have historically taken 4–7 years from filing. IPO-Pakistan's ongoing digitisation and examiner recruitment programme has improved timelines in some areas, but Pakistani patent prosecution requires long-horizon planning.

Response periods: Applicants typically receive 3 months to respond to examination actions, extendable on request.

Common Examination Outcomes

Most Pakistani patent prosecution follows one of three patterns:

Pattern 1 (Prior positive examination abroad): Applications entering Pakistan with a prior allowance or positive search report at the USPTO, EPO, or another major office tend to proceed through examination relatively smoothly, with formal rather than substantive objections being more common. The PPH framework is not yet fully operational between IPO-Pakistan and major IP offices, but the positive international track record carries significant weight.

Pattern 2 (Standard prosecution): Applications without prior international examination support receive substantive examination with prior art citations drawn from international databases. Novelty and inventive step rejections are addressed through standard argument and amendment.

Pattern 3 (Pharmaceutical applications): Pharmaceutical patent applications receive additional scrutiny — both in terms of patentability criteria (Section 10 exclusions, evergreening concerns) and in practice from civil society and generic manufacturer monitoring. Budget for more prosecution rounds and longer timelines for pharmaceutical applications.

Pakistan's Pharmaceutical Sector: Special Considerations

Pakistan has a significant domestic pharmaceutical manufacturing industry — one of the largest in South Asia. Companies including Getz Pharma, Searle, Ferozsons, and Martin Dow produce branded and generic pharmaceuticals for domestic use and regional export.

For originator pharmaceutical companies: Pakistan's patent environment for pharmaceuticals involves:

• Substantive patent examination (unlike South Africa and Nigeria's depository systems)
• Compulsory licensing provisions available under the Patents Ordinance for public health reasons
• A generic manufacturing sector that monitors pharmaceutical patent filings and, in some cases, actively challenges them
• DRAP (Drug Regulatory Authority of Pakistan) registration requirements that operate independently of patent status

For generic pharmaceutical companies: Pakistan's domestic manufacturing capability means that technology transfer arrangements and manufacturing licences with Pakistani pharmaceutical manufacturers can be commercially significant.

The data exclusivity gap: Unlike USMCA (which mandated 10-year biologic data exclusivity in Mexico), Pakistan does not have a robust data exclusivity framework for pharmaceutical products. This limits the regulatory exclusivity layer available to originator pharmaceutical companies independent of patent protection.

Pakistan's Growing Technology Sectors

Pakistan's technology landscape is evolving faster than its IP infrastructure, creating both opportunities and challenges:

IT and Software Services: Pakistan's technology export sector has grown rapidly, with exports exceeding USD $2.5 billion annually. Lahore, Karachi, and Islamabad have active technology communities. Software-implemented inventions with technical character — embedded systems, industrial control software, fintech infrastructure — are increasingly relevant patent subjects. The Pakistan Software Export Board (PSEB) actively promotes the sector.

Telecommunications: Pakistan has over 190 million mobile subscribers. Telecommunications infrastructure patents — network equipment, handset technology, spectrum management — are commercially relevant. The Pakistan Telecommunication Authority (PTA) regulates an active and competitive market.

Agriculture: Pakistan is a major agricultural economy — wheat, cotton, rice, and sugarcane are key crops. Agricultural technology patents — seed varieties, crop protection chemistry, precision agriculture equipment, irrigation technology — have long-term commercial relevance in a sector that accounts for approximately 20% of Pakistan's GDP.

Construction and Building Materials: Pakistan's infrastructure development — dams, highways, housing — drives substantial demand for construction technology, building materials, and related innovation.

Energy: Pakistan faces chronic energy shortfalls. Renewable energy — solar, wind — and grid efficiency technology are active investment areas with commercial relevance for energy technology patents.

Enforcement in Pakistan

The Intellectual Property Tribunal System

Pakistan established a dedicated Intellectual Property Tribunal (IPT) system in 2012 through the Intellectual Property Organization of Pakistan Act. IP tribunals operate in Karachi, Lahore, and Islamabad, with jurisdiction over civil and criminal IP matters.

Timeline: IP tribunal proceedings are faster than the general civil court backlog but still take 2–5 years for a first-instance judgment in contested cases. The relatively young IP tribunal system is developing jurisprudence and procedural efficiency.

Criminal enforcement: Pakistan's IP law includes criminal sanctions for infringement — fines and imprisonment for wilful infringement. Criminal enforcement is pursued through the Federal Investigation Agency's Intellectual Property Crime Unit (FIA-IPCU), which has conducted significant counterfeit goods raids, primarily for trademarks and copyrights. Criminal patent enforcement is rarer but available.

Preliminary injunctions: Available from IP tribunals and, in urgent cases, from the High Courts. Pakistan's courts apply standard balance of convenience tests. Preliminary injunctions in patent cases have been granted, particularly for pharmaceutical and consumer goods disputes.

Practical Enforcement Considerations

For foreign patent holders, the most practical enforcement approaches in Pakistan combine:

• Cease-and-desist correspondence from a reputable Pakistani IP law firm — in many cases, a formal letter citing the patent and asserting infringement is sufficient to deter smaller-scale infringement
• Customs border enforcement — the Pakistan Customs Service can be engaged for border detention of infringing imports
• Trade association leverage — Pakistan's pharmaceutical, textile, and manufacturing industry associations have internal dispute resolution mechanisms that can be more efficient than formal litigation
• Licensing rather than enforcement — for major Pakistani manufacturers, a licensing arrangement at Pakistani market-appropriate royalty rates is often more commercially valuable than enforcement costs

A Worked Scenario: Agricultural Technology Patent

A Dutch agricultural technology company developed a novel seed coating compound that significantly improved crop germination under water-stress conditions — particularly relevant to Pakistan's Punjab province, which faces recurrent drought and water management challenges.

Filing strategy: A direct national application filed at IPO-Pakistan claiming Paris Convention priority from the Dutch national filing — within the 12-month priority window. English specification, no translation required, modest filing fees. Examination request filed simultaneously.

First examination action (4.5 years after national phase entry): IMPI examiner cited two prior art references — a 2012 Indian patent application and a 2015 US academic paper — arguing that the combination of the two references made the claimed coating compound obvious. Examiner also raised an informal concern that the coating compound might fall within Pakistan's exclusion for plant-related inventions (Section 10) depending on how the compound was characterised.

Response: The applicant's patent agent distinguished the Indian patent (which used a different carrier material with different release kinetics) and the US paper (which described a laboratory-only formulation, not an industrially applicable compound). On the Section 10 concern, the agent clarified that the coating compound was a chemical composition — not a plant variety or biological process — and cited the explicit statutory text confining the exclusion to plant varieties and essentially biological production processes.

Result: After one further exchange clarifying a dependent claim, the patent was granted. Total prosecution time: approximately 7 years from the Pakistani filing date. Remaining term: 13 years — sufficient for the product's commercial lifecycle.

Commercial outcome: The granted Pakistani patent was included in a technology transfer agreement with a Pakistani agricultural company, which paid an upfront licence fee of USD $85,000 and ongoing royalties of 2% of domestic sales. The royalty stream, while modest in absolute terms, justified the relatively low filing cost and patient prosecution approach.

Pakistan-Specific Strategic Considerations

English language is the most underappreciated advantage. Pakistan's English-language patent proceedings eliminate translation costs entirely. A US, UK, or Australian specification filed directly — with minor formal adaptations — proceeds through IPO-Pakistan without translation overhead. This makes Pakistan one of the cheapest anglophone major markets to file in globally.

File early via Paris Convention — the 12-month window is tight. Unlike PCT countries where you have 30 months to decide on national phase entry, Pakistan's non-PCT status means you must file directly within 12 months of your earliest priority date. Build Pakistan into your filing calendar from day one if the commercial case justifies it — do not assume you can defer the decision as you would for a PCT jurisdiction.

Target agricultural and pharmaceutical technology specifically. These sectors have the clearest long-term commercial rationale for Pakistani patents given market size, domestic manufacturing capability, and technology import demand. Electronics, software, and fast-moving consumer technology may not grant quickly enough to provide meaningful protection.

Build a relationship with a Pakistani IP law firm before you need it. Pakistan's legal services sector has several strong IP boutiques and general commercial law firms with IP departments — particularly in Karachi and Lahore. Identifying and retaining local counsel before enforcement is needed positions you to act quickly when a dispute arises.

Pakistan's CPEC dimension: China-Pakistan Economic Corridor (CPEC), a major infrastructure and manufacturing investment programme, is bringing Chinese manufacturing and technology into Pakistan. Patent holders in infrastructure, construction, energy, and telecommunications technology should be aware that Chinese CPEC contractors may practise technology that is patented in Pakistan — creating both an enforcement scenario and a licensing opportunity.

Cost Summary

Pakistan is among the least expensive patent jurisdictions globally when accounting for the absence of translation costs. A Pakistani patent from direct filing to grant costs less than the translation of a specification into Japanese for a Japanese national phase entry.

Sources

1. IPO Pakistan (Intellectual Property Organization of Pakistan) — Official national IP authority; filing procedures, fee schedules, and e-IPO portal
2. Pakistan Patents Ordinance 2000 — Statutory framework for patent protection in Pakistan
3. WIPO — Pakistan Country Profile — Treaty memberships (note: Pakistan is not a PCT member) and IP office information

Information current as of April 2026. Patent fees, timelines, and office procedures change — verify with the national patent office before filing.